Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Calcipotriene
Generic Name
Calcipotriene
Active Ingredient
CalcipotrieneCategory
Vitamin D Analog [EPC]
Variants
8
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .05 mg/g | OINTMENT | TOPICAL | 51672-4154 |
| 50 ug/g | CREAM | TOPICAL | 66993-877 |
| 50 ug/g | AEROSOL, FOAM | TOPICAL | 51862-512 |
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Calcipotriene, you must consult a qualified healthcare professional.
| .05 mg/mL | SOLUTION | TOPICAL | 0713-0318 |
| 50 ug/g | CREAM | TOPICAL | 16714-763 |
| 50 ug/g | OINTMENT | TOPICAL | 66993-878 |
| 50 ug/g | CREAM | TOPICAL | 68462-501 |
| 50 ug/g | OINTMENT | TOPICAL | 68462-310 |
Detailed information about Calcipotriene
Calcipotriene is a topical Vitamin D3 analog used primarily to treat plaque psoriasis by regulating skin cell production. It works by binding to vitamin D receptors to slow the overgrowth of skin cells (keratinocytes).
For the treatment of Plaque Psoriasis, the standard adult dosage for calcipotriene (ointment, cream, or scalp solution) is a thin layer applied to the affected skin areas twice daily (once in the morning and once in the evening). Some patients may find that once-daily application is sufficient for maintenance after initial improvement.
Maximum Dosage Limit: It is clinically critical that adults do not exceed 100 grams per week of the cream or ointment. For the scalp solution, the limit is typically 60 mL per week. Exceeding these limits significantly increases the risk of systemic absorption, which can lead to elevated blood calcium levels (hypercalcemia), a potentially serious condition.
Calcipotriene use in children must be strictly supervised by a pediatric dermatologist.
Patients with known kidney disease should use calcipotriene with extreme caution. Since the kidneys are responsible for calcium homeostasis (balance), any systemic absorption of calcipotriene could exacerbate underlying mineral imbalances. Dose reduction or more frequent monitoring of serum calcium may be required.
Because calcipotriene is primarily metabolized in the liver, patients with severe hepatic impairment may have a reduced ability to clear the drug if it is absorbed systemically. While topical use is generally safe, healthcare providers may limit the total surface area treated to prevent accumulation.
Clinical studies have not identified significant differences in response between elderly and younger patients. However, because older adults are more likely to have reduced renal function or be taking other medications that affect calcium (like thiazide diuretics), a conservative approach to the total weekly dose is often recommended.
To ensure the best results and minimize side effects, follow these application steps:
If you miss a dose, apply it as soon as you remember. However, if it is almost time for your next scheduled application, skip the missed dose and return to your regular routine. Do not apply double the amount to make up for a missed dose, as this increases the risk of localized skin irritation.
An overdose of topical calcipotriene usually occurs through chronic over-application (exceeding the 100g/week limit) rather than a single large application.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or apply it to larger areas of your body without medical guidance.
Most patients tolerate calcipotriene well, but localized skin reactions are the most frequent complaints. These typically occur shortly after application and may diminish as the skin adjusts to the treatment.
Calcipotriene is for external use only. It must not be used in the eyes, mouth, or vagina. If the medication accidentally comes into contact with the eyes, it can cause severe irritation; rinse thoroughly with cool water immediately. Patients should be aware that calcipotriene is a potent metabolic agent; while it is applied to the skin, its effects can become systemic if the skin barrier is broken or if excessive amounts are used.
There are no FDA black box warnings for Calcipotriene. It has a well-established safety profile spanning over three decades of clinical use.
There are no medications that are absolutely contraindicated for use with calcipotriene, provided it is used topically and within dosage limits. However, it should not be used simultaneously with other potent Vitamin D analogs (like oral Calcitriol) unless under the strict supervision of a specialist, as this significantly compounds the risk of systemic Vitamin D toxicity.
Calcipotriene must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by a physician:
Calcipotriene is classified as Pregnancy Category C under the older FDA system. This means that animal reproduction studies have shown an adverse effect on the fetus (often related to skeletal variations when high doses were given orally), but there are no adequate and well-controlled studies in humans.
It is not known whether topical calcipotriene is excreted in human milk. Because many drugs are excreted in milk, caution should be exercised.
Calcipotriene is a synthetic Vitamin D3 analog that acts as a high-affinity ligand for the Vitamin D Receptor (VDR). Once it binds to the VDR in the cytoplasm of skin cells, the receptor-ligand complex translocates to the nucleus. There, it binds to Vitamin D Response Elements (VDRE) on specific genes.
This genetic 'switching' results in:
Common questions about Calcipotriene
Calcipotriene is primarily used for the topical treatment of chronic plaque psoriasis, a condition where skin cells grow too quickly and form thick, scaly patches. It is a synthetic form of Vitamin D3 that helps regulate skin cell production and maturation. By slowing down the overgrowth of these cells, it reduces the thickness and scaling of the psoriasis plaques. It is available in various forms, including creams, ointments, and scalp solutions, to treat different areas of the body. Your doctor may prescribe it as a safer, long-term alternative to steroid creams for managing your symptoms.
The most common side effects of calcipotriene are localized skin reactions at the site of application, such as burning, stinging, or itching. These sensations are usually temporary and occur shortly after the medication is applied to the skin. Some patients also report redness, dryness, or peeling of the skin surrounding the treated area. In most cases, these side effects are mild and tend to decrease as your skin becomes accustomed to the treatment. However, if you experience severe irritation or a rash that spreads, you should contact your healthcare provider for guidance.
There is no known direct chemical interaction between topical calcipotriene and alcohol consumption. Because the medication is applied to the skin and very little is absorbed into the bloodstream, alcohol does not typically interfere with how the drug works. However, it is important to note that alcohol is a common trigger for psoriasis flares in many patients and may interfere with the overall healing process. Drinking alcohol can also lead to dehydration, which may worsen skin dryness and irritation. It is best to discuss your alcohol intake with your doctor to see if it might be affecting your psoriasis management.
Calcipotriene is classified as Pregnancy Category C, meaning its safety in human pregnancy has not been fully established. Animal studies have shown some risks to the fetus when high doses were given orally, but topical use in humans results in much lower exposure. Most healthcare providers recommend using it during pregnancy only if the benefits clearly outweigh the potential risks. If you are pregnant or planning to become pregnant, your doctor may suggest limiting the amount of skin you treat to minimize any absorption. Always consult your obstetrician and dermatologist before starting or continuing this medication during pregnancy.
Most patients begin to see an improvement in the scaling of their psoriasis plaques within the first two weeks of consistent use. However, it typically takes longer—usually between four and eight weeks—to see a significant reduction in the thickness and redness of the lesions. It is important to continue applying the medication as directed by your doctor, even if you do not see immediate results. Full clearance of a plaque may take several months of steady treatment. If you do not see any improvement after eight weeks, your healthcare provider may need to adjust your treatment plan.
Unlike topical corticosteroids, calcipotriene does not usually cause a 'rebound' effect where your psoriasis returns significantly worse immediately after stopping. However, psoriasis is a chronic condition, and stopping the medication abruptly may lead to a gradual return of your symptoms. It is generally recommended to talk to your doctor before discontinuing treatment so they can help you transition to a maintenance schedule. They may suggest reducing the frequency of application rather than stopping all at once. Consistent use is key to keeping plaques under control for the long term.
If you miss a dose of calcipotriene, you should apply it as soon as you remember to the affected area. However, if it is nearly time for your next scheduled application, you should skip the missed dose and simply continue with your regular routine. You should never apply a double amount of the cream or ointment to make up for a missed dose, as this can increase the risk of skin irritation. Consistency is important for the medication to be effective, so try to use it at the same times each day. If you find yourself frequently forgetting doses, consider setting a reminder on your phone.
Calcipotriene is a topical medication and is not known to cause weight gain or other systemic metabolic changes like those seen with oral steroids. Because it works locally on the skin and has very limited absorption into the bloodstream, it does not affect your appetite or fat distribution. If you notice unexpected weight gain while using this medication, it is likely due to other factors or medications you may be taking. You should discuss any significant changes in your weight with your healthcare provider to determine the underlying cause. Calcipotriene's safety profile is generally focused on skin health and calcium balance rather than weight.
Calcipotriene can be used alongside many other medications, but some topical products can interfere with it. For example, products containing salicylic acid can inactivate calcipotriene if applied at the same time, so they should be used at different times of the day. It is also frequently used in combination with topical steroids, which can enhance its effectiveness and reduce skin irritation. However, you should avoid taking high doses of oral Vitamin D or calcium supplements without consulting your doctor, as this could increase the risk of high blood calcium levels. Always provide your healthcare provider with a full list of your current medications and supplements.
Yes, calcipotriene is available in several generic formulations, including creams, ointments, and scalp solutions. Generic versions are typically more cost-effective than brand-name products like Dovonex or Sorilux while containing the same active ingredient and providing the same clinical benefits. The availability of generics has made this important psoriasis treatment more accessible to a wider range of patients. When picking up your prescription, you can ask your pharmacist if a generic version is available for the specific form your doctor prescribed. Both brand-name and generic versions require a prescription from a licensed healthcare provider.
Other drugs with the same active ingredient (Calcipotriene)
While rare when used correctly, systemic absorption can lead to serious metabolic issues.
> Warning: Stop taking Calcipotriene and call your doctor immediately if you experience any of these:
The long-term safety of calcipotriene has been studied for up to one year in continuous use.
No FDA black box warnings are currently issued for calcipotriene. It is considered a safe and effective medication when used within the prescribed dosage limits (under 100g/week for adults).
Report any unusual symptoms or persistent skin changes to your healthcare provider to ensure your treatment plan remains safe and effective.
For most patients using standard amounts, routine blood work is not necessary. However, your healthcare provider may require monitoring in the following scenarios:
Calcipotriene is a topical medication with no known sedative or psychoactive effects. It does not impair the ability to drive or operate heavy machinery.
There are no direct chemical interactions between topical calcipotriene and alcohol. However, alcohol consumption is a known trigger for psoriasis flares in many individuals. Excessive drinking may reduce the overall efficacy of your psoriasis management plan.
One of the benefits of calcipotriene compared to topical steroids is that it does not typically cause a 'rebound' effect (where the disease returns significantly worse than before) when stopped. However, you should not stop treatment abruptly without consulting your doctor, as a gradual transition to a maintenance therapy may be better for long-term clearance.
> Important: Discuss all your medical conditions, especially any history of kidney stones or high calcium, with your healthcare provider before starting Calcipotriene.
Calcipotriene does not typically interfere with standard laboratory assays (like glucose or cholesterol tests). However, its systemic absorption can directly alter the results of:
For each major interaction, the mechanism is usually related to pharmacodynamic synergy—where two substances have the same effect on the body (in this case, raising calcium)—rather than a chemical interference. The management strategy is typically to monitor blood levels or adjust the timing of application.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those you only use occasionally.
There is a potential for cross-sensitivity with other Vitamin D analogs such as Calcitriol or Maxacalcitol. If you have reacted poorly to one form of topical Vitamin D, you are likely to react to others. However, there is no cross-sensitivity between calcipotriene and topical corticosteroids or coal tar treatments.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of bone disease or mineral imbalances, before prescribing Calcipotriene.
Calcipotriene is FDA-approved for use in children (specifically the ointment and cream for ages 12 and up, though some formulations have data for younger children).
In clinical trials, no overall differences in safety or effectiveness were observed between subjects over 65 and younger subjects.
Patients with a GFR (Glomerular Filtration Rate) below 60 mL/min should be monitored closely. The kidneys are the primary regulators of calcium and phosphate; if calcipotriene absorption occurs, a compromised kidney may not be able to compensate, leading to rapid onset of hypercalcemia.
While topical absorption is low, the liver is the site of calcipotriene metabolism. Patients with Child-Pugh Class C (severe) cirrhosis should be treated with the smallest effective dose over the smallest possible area to prevent any systemic accumulation of the drug.
> Important: Special populations require individualized medical assessment and often more frequent follow-up appointments to ensure the medication is working safely.
| Parameter | Value |
|---|---|
| Bioavailability | <6% (Topical, intact skin) |
| Protein Binding | Approx. 95% (to Vitamin D Binding Protein) |
| Half-life | 2-5 hours (systemic fraction) |
| Tmax | Not applicable for topical; systemic peak within 8-12 hours of large-scale application |
| Metabolism | Hepatic (CYP-mediated side-chain oxidation) |
| Excretion | Fecal (Major), Renal (Minor, ~15%) |
Calcipotriene is a Vitamin D Analog. Within the therapeutic area of dermatology, it is grouped with other non-steroidal anti-psoriatic agents. It is often compared to topical retinoids (like tazarotene) and calcineurin inhibitors (like tacrolimus), though its mechanism is distinctively focused on Vitamin D pathways.